pd168393 has been researched along with Carcinoma in Situ in 1 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, X | 1 |
| Zhang, H | 2 |
| Xiao, M | 1 |
| Kong, Y | 1 |
| Li, W | 1 |
1 other study available for pd168393 and Carcinoma in Situ
| Article | Year |
|---|---|
Inhibition of progression of PanIN through antagonizing EGFR.
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Disease Progression; Drug Screening Assays, Antit | 2015 |